Capula Management Ltd Boosts Stock Holdings in Kenvue Inc. $KVUE

Capula Management Ltd grew its holdings in shares of Kenvue Inc. (NYSE:KVUE) by 137.7% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 2,247,472 shares of the company’s stock after buying an additional 1,301,854 shares during the quarter. Kenvue accounts for approximately 0.3% of Capula Management Ltd’s holdings, making the stock its 8th biggest holding. Capula Management Ltd’s holdings in Kenvue were worth $38,746,000 as of its most recent SEC filing.

Other institutional investors have also recently made changes to their positions in the company. Oak Thistle LLC acquired a new position in Kenvue during the 4th quarter valued at about $1,563,000. Mirae Asset Global Investments Co. Ltd. grew its position in Kenvue by 25.8% in the 4th quarter. Mirae Asset Global Investments Co. Ltd. now owns 410,874 shares of the company’s stock worth $7,088,000 after purchasing an additional 84,219 shares during the last quarter. Calamos Advisors LLC increased its stake in shares of Kenvue by 24.1% in the first quarter. Calamos Advisors LLC now owns 3,351,000 shares of the company’s stock valued at $57,771,000 after purchasing an additional 651,000 shares during the period. Cohen Capital Management Inc. acquired a new stake in shares of Kenvue in the fourth quarter valued at approximately $2,448,000. Finally, Nomura Asset Management Co. Ltd. raised its holdings in shares of Kenvue by 21.5% during the fourth quarter. Nomura Asset Management Co. Ltd. now owns 3,491,548 shares of the company’s stock valued at $60,229,000 after buying an additional 618,720 shares during the last quarter. Institutional investors own 97.64% of the company’s stock.

Analysts Set New Price Targets

Several equities analysts have recently issued reports on KVUE shares. Barclays boosted their price objective on Kenvue from $18.00 to $19.00 and gave the stock an “equal weight” rating in a research report on Tuesday. Zacks Research downgraded Kenvue from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, July 7th. UBS Group lifted their target price on Kenvue from $18.00 to $20.00 and gave the company a “neutral” rating in a research note on Thursday, July 16th. Citigroup reduced their price target on Kenvue from $20.00 to $19.00 and set a “neutral” rating for the company in a research report on Wednesday, April 15th. Finally, Weiss Ratings raised Kenvue from a “hold (c-)” rating to a “hold (c)” rating in a report on Monday, June 15th. Three equities research analysts have rated the stock with a Buy rating and thirteen have assigned a Hold rating to the stock. According to MarketBeat, the stock has an average rating of “Hold” and a consensus price target of $19.58.

Insider Activity

In other news, General Counsel Matthew Orlando sold 38,491 shares of Kenvue stock in a transaction on Friday, May 8th. The stock was sold at an average price of $17.66, for a total transaction of $679,751.06. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Company insiders own 1.59% of the company’s stock.

Kenvue Trading Down 1.2%

Shares of NYSE:KVUE opened at $18.89 on Friday. The company has a 50 day moving average of $18.33 and a 200-day moving average of $17.91. The company has a current ratio of 0.98, a quick ratio of 0.70 and a debt-to-equity ratio of 0.67. The firm has a market cap of $36.28 billion, a P/E ratio of 22.23, a P/E/G ratio of 1.45 and a beta of 0.47. Kenvue Inc. has a twelve month low of $14.02 and a twelve month high of $22.87.

Kenvue (NYSE:KVUE) last posted its quarterly earnings data on Thursday, May 7th. The company reported $0.32 EPS for the quarter, beating analysts’ consensus estimates of $0.27 by $0.05. Kenvue had a net margin of 10.61% and a return on equity of 20.81%. The business had revenue of $3.91 billion for the quarter, compared to analyst estimates of $3.84 billion. During the same quarter last year, the business earned $0.24 earnings per share. The business’s revenue for the quarter was up 4.5% on a year-over-year basis. As a group, analysts anticipate that Kenvue Inc. will post 1.16 earnings per share for the current fiscal year.

Kenvue Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Wednesday, May 27th. Shareholders of record on Wednesday, May 13th were paid a dividend of $0.2075 per share. This represents a $0.83 dividend on an annualized basis and a yield of 4.4%. The ex-dividend date of this dividend was Wednesday, May 13th. Kenvue’s dividend payout ratio (DPR) is presently 97.65%.

Kenvue Profile

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.